All News
Board Denies Doc a License for Third Time; Doc Sentenced to 10 Years; Nurse Gets 17
(MedPage Today) -- For the third time, the Iowa Board of Medicine has refused to issue a license to Brett Snodgrass, MD.
Read MoreCan Keir Starmer’s six targets turn the tide? What the PM said – and what it all means
They might have sounded a tad familiar, but the prime minister is hoping these pledges will win back trustSir Keir Starmer’s speech on Thursday mentioned the word “milestone” eight times and “
Read MoreBovine colostrum, raw milk and cortisol face: the biggest wellness trends of 2024
Will lowering cortisol levels help with puffiness? Do you need to take magnesium? What’s underconsumption core? We’re here to helpWe all want to be well – to feel good or, at least, not feel bad
Read MoreEmpagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression
(MedPage Today) -- Use of empagliflozin (Jardiance) was not linked to a lower risk of incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase-4 (DPP-4) inhibitors among pati
Read MoreSTAT+: Health plans with high deductibles are becoming less popular
Mounting evidence shows that the push toward high-deductible health insurance plans has backfired.
Read MoreGet pumped for Trump admin confirmation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.
Read MoreUntangling GLP-1 Risks: Are Side Effects Overblown?
(MedPage Today) -- In part two of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Karl Nadolsky, DO, and Fatima Cody Stanford, MD, MPH, MPA, MBA, dive into
Read MoreWhat we know about the killing of UnitedHealthCare’s CEO
Good morning, there was so much news yesterday, I barely got a chance to look at my Spotify Wrapped data.
Read MoreAstraZeneca replaces benched exec in China
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning.
Read MoreSTAT+: Why Applied Therapeutics has a credibility problem
Applied Therapeutics' CEO Shoshana Shendelman has a debilitating credibility problem, @adamfeuerstein writes.
Read More